CSX Corporation, a key player in U.S. railroads, excels in logistics, focusing on efficiency, profitability, and reducing emissions under new CEO Joe Hinrichs. Despite revenue stagnation, CSX maintains high profitability through Precision Scheduled Railroading, cost optimization, and strategic investments in intermodal transport and infrastructure modernization. The company's shares are undervalued, trading at discounts compared to historical and peer averages, presenting a buying opportunity with a potential 16.31% price increase.

Johnson Fistel Investigates Fairness of Proposed Sale of AvidXchange Holdings to TPG Inc. — Neutral
AVDX TPG GlobeNewsWire — May 07, 2025SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of AvidXchange Holdings, Inc. (NASDAQ: AVDX) breached their fiduciary duties in connection with the proposed sale of the Company to TPG Inc. (NASDAQ: TPG).

Gold market analysis for May 7 - key intra-day price entry levels for active traders — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — May 07, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress — Neutral
ATHE GlobeNewsWire — May 07, 2025MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster presentations related to Alterity's clinical programs in Multiple System Atrophy (MSA) will be featured at the 2025 International MSA Congress taking place May 9 - 11, 2025 in Boston, MA, USA. The Congress is presented by Mission MSA, a non-profit organization dedicated to improving the quality of life and building hope for people affected by MSA through support services, educational …

These 3 Rock Star Entertainment Stocks Are Dominating 2025 — Positive
RBLX SPOT TME MarketBeat — May 07, 2025The market has been treading through rough waters in 2025, but several stocks in the entertainment industry are among the stars shining the brightest despite this. While many sectors have struggled to gain traction amid economic uncertainty and mixed earnings results, a select group of entertainment names has managed to stand out.

ENR Q2 Earnings Miss, FY25 Guidance Down, Stock Falls Nearly 8% — Negative
ENR Zacks Investment Research — May 07, 2025Energizer's fiscal second-quarter net sales and earnings decline year over year. The company lowers its fiscal 2025 guidance amid ongoing macroeconomic headwinds.

Yes, Consumer Staples are boring but nothing is boring about making money.

Ares Commercial Real Estate (ACRE) Beats Q1 Earnings Estimates — Positive
ACRE Zacks Investment Research — May 07, 2025Ares Commercial Real Estate (ACRE) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.62 per share a year ago.

Entegris (ENTG) Q1 Earnings and Revenues Lag Estimates — Negative
ENTG Zacks Investment Research — May 07, 2025Entegris (ENTG) came out with quarterly earnings of $0.67 per share, missing the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.68 per share a year ago.

National Vision (EYE) Beats Q1 Earnings and Revenue Estimates — Positive
EYE Zacks Investment Research — May 07, 2025National Vision (EYE) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.30 per share a year ago.

Acushnet (GOLF) Q1 Earnings and Revenues Surpass Estimates — Positive
GOLF Zacks Investment Research — May 07, 2025Acushnet (GOLF) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.43 per share a year ago.

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates — Positive
LIVN Zacks Investment Research — May 07, 2025LivaNova (LIVN) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.73 per share a year ago.

Axalta Coating Systems (AXTA) Beats Q1 Earnings Estimates — Positive
AXTA Zacks Investment Research — May 07, 2025Axalta Coating Systems (AXTA) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.48 per share a year ago.

Radware (RDWR) Beats Q1 Earnings and Revenue Estimates — Positive
RDWR Zacks Investment Research — May 07, 2025Radware (RDWR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.16 per share a year ago.

EpicQuest Education Enters into Key Agreement as Catalyst for Recruiting from Africa and the Middle East — Neutral
EEIQ PRNewsWire — May 07, 2025The New Recruiting Initiative has the Potential to Bring 525 Students from these Regions into Davis University over the Term of the Agreement MIDDLETOWN, Ohio , May 7, 2025 /PRNewswire/ -- EpicQuest Education Group International Limited (NASDAQ: EEIQ), ("EpicQuest Education", "EEIQ" or the "Company"), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced that on May 1, 2025, its owned and operated Davis University ("Davis") entered into an Agency Agreement (the "Agreement") with MSM Unify to drive student recruitment from Africa and the Middle East on behalf of Davis University. …

Liberty Media Corporation Reports First Quarter 2025 Financial Results — Neutral
FWONA Business Wire — May 07, 2025ENGLEWOOD, Colo.--(BUSINESS WIRE)--LIBERTY MEDIA CORPORATION REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS.

Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
ATNM Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=147265&wire=1 or contact Joseph E. Levi, Esq.

Ibotta, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 16, 2025 to Discuss Your Rights - IBTA — Neutral
IBTA Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=147264&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of Zenas BioPharma, Inc. (ZBIO) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
ZBIO Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=147266&wire=1 or contact Joseph E. Levi, Esq.

STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update — Neutral
SSKN GlobeNewsWire — May 07, 2025HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2025 financial results on Wednesday, May 14, 2025 after the market close.
